ORAL CAVITY SQUAMOUS CELL CARCINOMA
Clinical trials for ORAL CAVITY SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for incurable head and neck cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs (IRX-2 regimen and durvalumab) in 19 patients with advanced head and neck cancer that could not be cured with standard treatments. The main goals were to check safety and see if the drugs could boost the immune response ins…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
New combo shows promise for head and neck cancer patients unable to take standard chemo
Disease control CompletedThis study tested two different drugs—durvalumab or cetuximab—given together with radiation therapy for people with advanced head and neck cancer who cannot take the standard chemotherapy drug cisplatin. The goal was to see which combination works better and is safer. A total of …
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Virtual planning may improve jaw surgery outcomes for oral cancer patients
Symptom relief CompletedThis study looked at 132 adults with oral or throat cancer who needed jawbone removal and reconstruction using a bone flap from the leg. Half had standard surgery, and half had surgery planned with 3D virtual tools. The main goal was to see if virtual planning improved quality of…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: UNICANCER • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC